Showing results (451-460 of 586) with videos related to

Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumorsTimothy A Yap, Laura Vidal, Jan Adam, et al.
Singapore Medical Journal|November 1, 2012
Preimplantation genetic diagnosis of chromosome translocations by analysis of polymorphic short tandem repeatsSeong Feei Loh, Peng Cheang Wong, Boran Jiang, et al.
Journal of the American Chemical Society|September 9, 2025
Structural Basis for HIV-1 Maturation Inhibition by PF-46396 Determined by MAS NMRRoman Zadorozhnyi, Caitlin M Quinn, Kaneil K Zadrozny, et al.
ESMO Open|November 12, 2025
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Structural Basis for HIV-1 Maturation Inhibition by PF-46396 Determined by MAS NMRRoman Zadorozhnyi, Caitlin M Quinn, Kaneil K Zadrozny, et al.
The Journal of Clinical Investigation|October 5, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumorsLulu Wang, Lin Yang, Chen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2025
First-In-Human Phase 1/2a Study of the First-In-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast CancerTimothy A Yap, Jonathan W Goldman, Shaveta Vinayak, et al.
Cancer|October 8, 2016
A study of motivations and expectations of patients seen in phase 1 oncology clinicsSaoirse O Dolly, Eleftheria Kalaitzaki, Martina Puglisi, et al.
NPJ Precision Oncology|July 7, 2025
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanomaNatalie Y L Ngoi, Ian M Silverman, Adrienne Johnson, et al.
Pageof 59